None listed
Conditions
Brief summary
This study will explore the role that supervised exercise training has in helping Stage I or II lung cancer patients to recover. Who is it for? You can join this study if you have previously had a lung resection (lobectomy) for lung cancer (Stage I or II non-small cell). With or without chemotherapy, and live in the metropolitan Perth area. Trial Details Following completion of previous treatment for lung cancer (surgery with or without chemotherapy), you will be randomised either to a group that receives 8 weeks of supervised exercise training, or usual care where you will be followed up by weekly phone calls for general discussion about your recover. Measures will be made before and after this 'intervention' period. Specifically, measures will be made of; (i) lung function, (ii) exercise capacity, (iii) disease-specific health-related quality of life, (iv) feelings of anxiety and depression, (v) peripheral muscle force (i.e. strength) and, (vi) daily physical activity. This trial will be the first randomised controlled trial of supervised out-patient exercise training in this patient population, and look to optimise recovery for patients following lung cancer resection.
Interventions
The exercise training program will be embedded within the pulmonary rehabilitation programs currently offered by the Physiotherapy Departments at Sir Charles Gairdner Hospital and Royal Perth Hospital. The 8-week training program will consist of 60 minutes training sessions which patients will attend three times per week. Circuit training will include aerobic (walking and cycling) and resistance training (upper and lower limbs). All sessions will be fully supervised by an experienced physiotherapist.
Sponsors
Study design
Eligibility
Inclusion criteria
Patients following lobectomy for lung cancer (Stage I or II non-small cell) residents in metropolitan Perth will be eligible to participate in this study
Exclusion criteria
Exclusion criteria will comprise; (i) patients undergoing pneumonectomy, (ii) presence of any co-morbid condition thought to compromise patient safety during the assessments, (iii) severe musculoskeletal limitations that would impact on the exercise measures, (iv) participation in a program of supervised exercise training in the last three months and, (v) inability to understand spoken or written English.